SH-SY5Y

From WikiMD's WELLNESSPEDIA

SH-SY5Y is a human derived neuroblastoma cell line. This cell line is commonly used in scientific research for the study of neuronal function and differentiation. It is also used in the study of Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases.

History[edit]

The SH-SY5Y cell line was first established in the 1970s. It was derived from a bone marrow biopsy taken from a four-year-old female with neuroblastoma. The cell line has been used extensively in research since its establishment.

Characteristics[edit]

SH-SY5Y cells are adherent cells that grow in a monolayer. They have a doubling time of approximately 24 to 48 hours. The cells are capable of differentiating into neuron-like cells when treated with agents such as retinoic acid or brain-derived neurotrophic factor (BDNF).

Use in Research[edit]

SH-SY5Y cells are commonly used in research due to their ability to differentiate into neuron-like cells. This makes them a useful model for studying neuronal function and differentiation. They are also used in the study of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Alzheimer's Disease[edit]

In Alzheimer's disease research, SH-SY5Y cells are often used to study the effects of amyloid beta peptides on neuronal cells. They are also used to investigate the role of various genes and proteins in the disease process.

Parkinson's Disease[edit]

In Parkinson's disease research, SH-SY5Y cells are used to study the effects of alpha-synuclein aggregation on neuronal cells. They are also used to investigate the role of various genes and proteins in the disease process.

See Also[edit]


SH-SY5Y[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.